Archives

Background

Leaders and pioneers in immunotherapy coming together with cutting-edge research and their intellectual property

Read More

What are Monoclonal Antibodies (mAbs)?

mAbs harness the body's own immune system to attack cancer cells, binding themselves based upon cancer’s cellular signature

Read More

Tailoring Therapies for Patient Segments

Precision medicine strategy for every molecule

Read More

Background

  • Leaders and pioneers in immunotherapy coming together with cutting-edge research and their intellectual property
  • Intellectual property includes both novel and proven antibody targeting mechanisms in the areas of oncology and immunology
  • mAbs that bind specific targets on cells to trigger a response from the body’s own immune system
  • Several molecules have already been identified by AR Pharma
  • Currently conducting evaluation of efficacy and toxicity and preparing for clinical trials
  • Personalized medicine (immunotherapy) will be the future of the Healthcare Industry

.